Pharmacology Watch – November 1, 2013
November 1, 2013
View Issues
-
Medications for Risk Reduction of Breast Cancer in Women
Evidence-based updates in clinical pharmacology.
In this issue: USPSTF issues new guidelines for risk reduction of breast cancer; safety of Chantix in patients with depression; polypills for cardiovascular disease; and FDA actions.
-
Chantix safe in patients with depression
-
Polypills for cardiovascular disease
-
FDA Actions